| Trial registration number
|
NCT05133635 |
Full text link
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05133635
|
First author
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Ruslan Abdullayev
|
Contact
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
2021-11-24
|
Recruitment status
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Withdrawn
|
Study design
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
unclear
|
Study aim
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
patients with covid-19 pneumonia treated in the intensive care unit
clinical deterioration during intensive care follow-up
first 14 days from the covid-19 diagnosis
|
Exclusion criteria
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
more than 14 days passed from the covid-19 diagnosis
clinical and laboratory signs of secondary bacterial infection
|
Number of arms
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Marmara University
|
Inclusion age min
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
70
|
Countries
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
None
|
Type of patients
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Critical disease at enrollment
|
Severity scale
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
8: Critical disease at enrollment
|
Total sample size
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
0
|
primary outcome
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Blood analysis;Clinical condition
|
Notes
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
Phase 4
|
Arms
Last imported at : Nov. 25, 2021, 9 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 798, "treatment_name": "Methylprednisolone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]
|